InsiderTrades.com logo
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.

IOVA Insider Trading

Insider Ownership Percentage: 12.10%
Insider Buying (Last 12 Months): $2,287,500.00
Insider Selling (Last 12 Months): $503,000.00

Iovance Biotherapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Iovance Biotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Iovance Biotherapeutics Share Price & Price History

Current Price: $7.38
Price Change: ▲ Price Increase of +0.16 (2.22%)
As of 12/20/2024 06:40 PM ET

This chart shows the closing price history over time for IOVA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Could This Tiny Device Help You Make an Extra $30k a Year?
From Brownstone Research   |   Ad
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
Click here to see the details because I believe a lot of people will get rich.

Iovance Biotherapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/12/2024Ryan D MaynardDirectorSell50,000$10.06$503,000.007,500View SEC Filing Icon  
2/20/2024Merrill A McpeakDirectorBuy250,000$9.15$2,287,500.00320,150View SEC Filing Icon  
9/18/2023Merrill A McpeakDirectorBuy10,000$5.56$55,600.00248,633View SEC Filing Icon  
9/15/2023Wayne P. RothbaumDirectorBuy5,000,000$5.30$26,500,000.0023,067,333View SEC Filing Icon  
12/21/2022Merrill A McpeakDirectorBuy10,000$6.15$61,500.0070,150View SEC Filing Icon  
12/2/2022Wayne P. RothbaumDirectorBuy10,000,000$6.50$65,000,000.0018,067,333View SEC Filing Icon  
11/28/2022Frederick G. VogtCEOBuy1,000$5.98$5,980.002,000View SEC Filing Icon  
11/28/2022Merrill A McpeakDirectorBuy10,000$6.18$61,800.00228,633View SEC Filing Icon  
11/23/2022Iain D. DukesDirectorBuy10,000$6.10$61,000.0022,000View SEC Filing Icon  
6/1/2022Frederick G. VogtCEOBuy1,000$6.44$6,440.001,000View SEC Filing Icon  
5/31/2022Merrill A McpeakDirectorBuy10,000$6.84$68,400.0020,150View SEC Filing Icon  
See Full Table
First JFK… next Elon?
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.

SEC Filings (Institutional Ownership Changes) for Iovance Biotherapeutics (NASDAQ:IOVA)

77.03% of Iovance Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IOVA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Iovance Biotherapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/19/2024Principal Financial Group Inc.4,033,184$37.87M0.0%+59.0%1.323%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.100,229$0.98M0.0%+9.2%0.033%Search for SEC Filing on Google Icon
11/21/2024SkyView Investment Advisors LLC20,000$0.19M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/18/2024Arete Wealth Advisors LLC34,600$0.33M0.0%-45.4%0.011%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC5,648,995$53.05M0.0%-2.4%1.853%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC604,584$5.68M0.0%+118.8%0.198%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP129,482$1.22M0.0%+10.3%0.042%Search for SEC Filing on Google Icon
11/15/2024State Street Corp13,201,978$123.97M0.0%+4.6%4.332%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp223,107$2.10M0.0%+35.8%0.073%Search for SEC Filing on Google Icon
11/15/2024NFJ Investment Group LLC189,655$1.78M0.1%-4.4%0.062%Search for SEC Filing on Google Icon
11/15/2024Centiva Capital LP16,625$0.16M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH34,000$0.33M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/14/2024PFM Health Sciences LP132,152$1.24M0.1%-13.5%0.043%Search for SEC Filing on Google Icon
11/14/2024Portland Investment Counsel Inc.40,000$0.38M0.1%+33.3%0.013%Search for SEC Filing on Google Icon
11/14/2024Braidwell LP217,928$2.05M0.1%-85.1%0.072%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC23,679$0.22M0.0%N/A0.008%Search for SEC Filing on Google Icon
11/14/2024Captrust Financial Advisors49,606$0.47M0.0%+95.0%0.016%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC13,665$0.13M0.0%-45.6%0.004%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1,946,842$18.28M0.0%-2.4%0.639%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets113,724$1.07M0.0%-75.5%0.037%Search for SEC Filing on Google Icon
11/13/2024FMR LLC82,662$0.78M0.0%+79.2%0.027%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company311,907$2.93M0.0%-7.0%0.102%Search for SEC Filing on Google Icon
11/13/2024DRW Securities LLC12,854$0.12M0.0%N/A0.004%Search for SEC Filing on Google Icon
11/12/2024Pekin Hardy Strauss Inc.33,050$0.31M0.0%-5.7%0.012%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC54,070$0.51M0.0%+53.2%0.019%Search for SEC Filing on Google Icon
11/12/2024Eagle Asset Management Inc.1,356,779$12.74M0.1%-30.0%0.485%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.1,913,144$17.96M0.0%-3.6%0.684%Search for SEC Filing on Google Icon
11/9/2024Landscape Capital Management L.L.C.65,525$0.62M0.1%N/A0.023%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC97,958$0.92M0.0%N/A0.035%Search for SEC Filing on Google Icon
11/8/2024Grandfield & Dodd LLC30,070$0.28M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/7/2024LMR Partners LLP41,211$0.39M0.0%-32.7%0.015%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC2,819$26K0.0%-43.7%0.001%Search for SEC Filing on Google Icon
11/6/2024Curi RMB Capital LLC108,637$1.02M0.0%+49.8%0.039%Search for SEC Filing on Google Icon
11/6/2024Pier 88 Investment Partners LLC44,180$0.42M0.1%-24.6%0.016%Search for SEC Filing on Google Icon
11/6/2024Saturna Capital Corp20,553$0.19M0.0%+7.0%0.007%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.144,280$1.36M0.0%+399.4%0.052%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP25,824$0.24M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC61,759$0.58M0.0%+156.0%0.022%Search for SEC Filing on Google Icon
11/2/2024XML Financial LLC14,500$0.14M0.0%+7.4%0.005%Search for SEC Filing on Google Icon
11/1/2024Assetmark Inc.12,853$0.12M0.0%+48.0%0.005%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.4,033,184$37.87M0.0%+59.0%1.441%Search for SEC Filing on Google Icon
10/30/2024Beacon Financial Advisory LLC21,120$0.20M0.1%+42.7%0.008%Search for SEC Filing on Google Icon
10/29/2024Farther Finance Advisors LLC15,389$0.15M0.0%+142.3%0.005%Search for SEC Filing on Google Icon
10/28/2024Creative Financial Designs Inc. ADV21,740$0.20M0.0%+59.3%0.008%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC1,679,157$15.77M0.9%+2.6%0.600%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE19,655$0.19M0.0%-30.9%0.007%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.58,376$0.55M0.1%+77.6%0.021%Search for SEC Filing on Google Icon
10/24/2024Clear Harbor Asset Management LLC17,550$0.17M0.0%-43.0%0.006%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.10,978$0.11M0.0%+31.4%0.004%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.351,449$3.30M0.2%-4.5%0.126%Search for SEC Filing on Google Icon
10/22/2024Bank Pictet & Cie Europe AG19,368$0.18M0.0%-54.9%0.007%Search for SEC Filing on Google Icon
10/16/2024nVerses Capital LLC15,800$0.15M0.1%N/A0.006%Search for SEC Filing on Google Icon
10/16/2024Vontobel Holding Ltd.18,940$0.18M0.0%+32.5%0.007%Search for SEC Filing on Google Icon
10/16/2024SeaCrest Wealth Management LLC20,406$0.19M0.0%-5.9%0.007%Search for SEC Filing on Google Icon
10/11/2024Creative Planning73,489$0.69M0.0%+2.6%0.026%Search for SEC Filing on Google Icon
10/11/2024ORG Wealth Partners LLC9,432$89K0.0%N/A0.003%Search for SEC Filing on Google Icon
10/10/2024Shaker Investments LLC OH100,712$0.95M0.4%+27.7%0.036%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC17,071$0.16M0.0%+11.6%0.006%Search for SEC Filing on Google Icon
10/8/2024Brookstone Capital Management20,055$0.19M0.0%+43.9%0.007%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB74,800$0.70M0.0%+18.2%0.027%Search for SEC Filing on Google Icon
8/19/2024B. Riley Wealth Advisors Inc.13,296$0.11M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC25,933,142$207.98M4.9%+34.6%9.267%Search for SEC Filing on Google Icon
8/16/2024Creative Planning71,593$0.57M0.0%-7.1%0.026%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC35,286$0.28M0.0%-9.0%0.013%Search for SEC Filing on Google Icon
8/16/2024Cim Investment Management Inc.31,172$0.25M0.1%+126.3%0.011%Search for SEC Filing on Google Icon
8/15/2024Long Focus Capital Management LLC4,132,000$33.14M1.3%+195.1%1.477%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company335,513$2.69M0.0%-6.5%0.120%Search for SEC Filing on Google Icon
8/15/2024Dark Forest Capital Management LP44,858$0.36M0.1%N/A0.016%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC11,477$92K0.0%-71.3%0.004%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC257,543$2.07M0.0%N/A0.092%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP1,612,055$12.93M0.0%N/A0.576%Search for SEC Filing on Google Icon
8/14/2024Xponance Inc.16,279$0.13M0.0%+13.0%0.006%Search for SEC Filing on Google Icon
8/14/2024Magnetar Financial LLC82,363$0.66M0.0%N/A0.029%Search for SEC Filing on Google Icon
8/14/2024Hood River Capital Management LLC2,732,427$21.91M0.5%+4.1%0.976%Search for SEC Filing on Google Icon
8/14/2024EverSource Wealth Advisors LLC6,609$58K0.0%N/A0.002%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC49,061$0.39M0.0%-21.1%0.018%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC124,660$1M0.0%+33.1%0.045%Search for SEC Filing on Google Icon
8/13/2024Ensign Peak Advisors Inc74,592$0.60M0.0%+13.4%0.027%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.284,761$2.28M0.0%-14.5%0.102%Search for SEC Filing on Google Icon
8/12/2024Seven Eight Capital LP77,240$0.62M0.1%-55.7%0.028%Search for SEC Filing on Google Icon
8/12/2024Vanguard Personalized Indexing Management LLC22,085$0.18M0.0%+27.2%0.008%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.40,912$0.33M0.0%+48.2%0.015%Search for SEC Filing on Google Icon
8/10/2024Virtu Financial LLC94,099$0.76M0.1%N/A0.034%Search for SEC Filing on Google Icon
8/9/2024Edgestream Partners L.P.99,605$0.80M0.0%N/A0.036%Search for SEC Filing on Google Icon
8/9/2024Pekin Hardy Strauss Inc.35,050$0.28M0.0%-18.6%0.013%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP2,265,555$18.17M0.0%-21.1%0.810%Search for SEC Filing on Google Icon
8/8/2024Wealthspire Advisors LLC57,000$0.46M0.0%N/A0.020%Search for SEC Filing on Google Icon
8/8/2024Parametrica Management Ltd261,090$2.09M2.8%+98.4%0.093%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.203,038$1.63M0.0%-40.0%0.073%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC1,636,025$13.12M0.8%-4.5%0.585%Search for SEC Filing on Google Icon
8/7/2024Headlands Technologies LLC16,067$0.13M0.0%N/A0.006%Search for SEC Filing on Google Icon
8/7/2024Daiwa Securities Group Inc.8,813$71K0.0%+754.0%0.003%Search for SEC Filing on Google Icon
8/7/2024Choreo LLC14,354$0.12M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC5,003$40K0.0%+1,237.7%0.002%Search for SEC Filing on Google Icon
8/6/2024Pier 88 Investment Partners LLC58,580$0.47M0.1%+155.8%0.021%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC24,124$0.19M0.0%N/A0.009%Search for SEC Filing on Google Icon
8/6/2024Candriam S.C.A.500,033$4.01M0.0%-52.8%0.179%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System54,734$0.44M0.0%+3.8%0.020%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc284,878$2.29M0.0%-43.6%0.102%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers368,800$2.96M0.0%-5.8%0.132%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Iovance Biotherapeutics logo
Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It also develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer (NSCLC) and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
Read More on Iovance Biotherapeutics

Today's Range

Now: $7.38
Low: $7.07
High: $7.44

50 Day Range

MA: $9.41
Low: $7.22
High: $12.28

52 Week Range

Now: $7.38
Low: $6.70
High: $18.33

Volume

10,115,762 shs

Average Volume

7,191,267 shs

Market Capitalization

$2.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.55

Who are the company insiders with the largest holdings of Iovance Biotherapeutics?

Iovance Biotherapeutics' top insider shareholders include:
  1. Wayne P Rothbaum (Director)
  2. Merrill A Mcpeak (Director)
  3. Ryan D Maynard (Director)
Learn More about top insider investors at Iovance Biotherapeutics.

Who are the major institutional investors of Iovance Biotherapeutics?

Iovance Biotherapeutics' top institutional shareholders include:
  1. State Street Corp — 4.33%
  2. Geode Capital Management LLC — 1.85%
  3. Principal Financial Group Inc. — 1.44%
  4. Principal Financial Group Inc. — 1.32%
  5. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.64%
  6. Charles Schwab Investment Management Inc. — 0.68%
Learn More about top institutional investors of Iovance Biotherapeutics stock.

Which major investors are selling Iovance Biotherapeutics stock?

During the last quarter, IOVA stock was sold by these institutional investors:
  1. Braidwell LP
  2. Eagle Asset Management Inc.
  3. BNP Paribas Financial Markets
  4. Geode Capital Management LLC
  5. Charles Schwab Investment Management Inc.
  6. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  7. Arete Wealth Advisors LLC
  8. The Manufacturers Life Insurance Company

Which major investors are buying Iovance Biotherapeutics stock?

During the last quarter, IOVA stock was acquired by institutional investors including:
  1. Principal Financial Group Inc.
  2. Principal Financial Group Inc.
  3. State Street Corp
  4. Barclays PLC
  5. Victory Capital Management Inc.
  6. Intech Investment Management LLC
  7. Jane Street Group LLC
  8. Landscape Capital Management L.L.C.
Within the last year, these company insiders have bought Iovance Biotherapeutics stock:
  1. Wayne P Rothbaum (Director)
  2. Merrill A Mcpeak (Director)
Learn More investors buying Iovance Biotherapeutics stock.
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.